Effects of urantide as a UT receptor antagonist on the signal molecules of NF-κB pathway in mice with acute liver failure

LIU Liang-ming,YE Chang-gen,LIANG Dong-yu,YU Fang-pin,ZHAO Liang,SUN Shui-lin,ZHANG Ji-xiang

DOI: https://doi.org/10.3969/j.issn.1008-1704.2013.02.006

2013-01-01

Abstract:Objective To investigate the effects of urantide on the signal molecules of NF-κB pathway in mice with acute liver failure. Methods Twenty four male BALB/c mices were randomly divided into 4 equal groups to be pre-treated with urantide or normal saline (NS) by tail intravenous injection. The mices were attacked with lipopolysaccharide (LPS)/D-galactosamine (GalN) or NS via intraperitoneal injection 30 minutes later. Livers were sampled 12 h after the attack, and subjected to extract plasmosin and nucleoprotein. Protein expression was detected by Western blot; DNA binding activity of NF-κB was evaluated by EMSA. Results There were not statistical differences in IκB-α protein expression of the cytoplasm among the four groups (P>0.05); However, the levels of p-IκB-α protein were significantly higher in model (urantide- LPS/GalN+) and pretreatment model (urantide+ LPS/GalN+) than those in control (urantide- LPS/GalN-) and pretreatment control group (urantide+ LPS/GalN-) (0.63±0.10), (0.31±0.05) vs (0.14±0.02), (0.14±0.01), P<0.01, respectively. Compared to model group, pretreatment model mice had significant lower levels of cytoplamic p-IκB-α protein (0.31±0.05) vs (0.63±0.10),P<0.01. Nuclear NF-κB p65 levels were also significantly higher in model and pretreatment model group than those in control and pretreatment control group (1.11±0.32), (0.69±0.14) vs (0.10±0.03), (0.13±0.01), P<0.01, respectively. While p65 levels of pretreatment model were lower than those of model group (0.69±0.14) vs (1.11±0.32), P<0.05. In addition, DNA binding activities of NF-κB were significantly higher in model and pretreatment model group than those in control and pretreatment control group (4.68±1.03), (1.60±0.37) vs (1.00±0.16), (1.01±0.10), P<0.01, respectively. However, pretreatment model group had a lower DNA binding activity of NF-κB level than that in model group (1.60±0.37) vs (4.68±1.03), P<0.01. Conclusion NF-κB signal activation induced by LPS/GalN attack can be inhibited by urantide, an antagonist of UT receptor.